These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1398500

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Gallbladder motility and cholecystokinin secretion during continuous enteral nutrition.
    Ledeboer M, Masclee AA, Biemond I, Lamers CB.
    Am J Gastroenterol; 1997 Dec; 92(12):2274-9. PubMed ID: 9399769
    [Abstract] [Full Text] [Related]

  • 43. Inhibitory effect of atropine on cholecystokinin-induced gallbladder contraction in man.
    Gullo L, Bolondi L, Priori P, Casanova P, Labò G.
    Digestion; 1984 Dec; 29(4):209-13. PubMed ID: 6468768
    [Abstract] [Full Text] [Related]

  • 44. Dose-response effects of oral loxiglumide on postprandial gall-bladder emptying in man.
    Malesci A, De Fazio C, Festorazzi S, Bonato C, Valentini A, Tacconi M, Bekkering M, Giacovelli G, D'Amato M, Rovati LC.
    Arzneimittelforschung; 1992 Nov; 42(11):1359-62. PubMed ID: 1492852
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Effects of cholecystokinin and its antagonists on the GI tract. Potent inhibition of gastrointestinal motility by loxiglumide].
    Schmidt WE.
    Fortschr Med; 1992 Oct 10; 110(28):521-2. PubMed ID: 1398411
    [No Abstract] [Full Text] [Related]

  • 49. Opposite effects of cholestyramine and loxiglumide on gallbladder dynamics in humans.
    Palasciano G, Portincasa P, Belfiore A, Baldassarre G, Albano O.
    Gastroenterology; 1992 Feb 10; 102(2):633-9. PubMed ID: 1732132
    [Abstract] [Full Text] [Related]

  • 50. Inhibitory effect of intraduodenal infusion of loxiglumide on pancreatic exocrine secretion.
    Tanikawa M, Hayakawa T, Kondo T, Shibata T, Kitagawa M, Kodaira T, Hamaoka T.
    Arzneimittelforschung; 1993 Jan 10; 43(1):35-9. PubMed ID: 8447844
    [Abstract] [Full Text] [Related]

  • 51. Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation.
    Höcker M, Schmidt WE, Creutzfeldt W, Choudhury AR, Nustede R, Schafmayer A, Fölsch UR.
    Regul Pept; 1992 Feb 18; 37(3):255-69. PubMed ID: 1557514
    [Abstract] [Full Text] [Related]

  • 52. Elemental diet stimulates gallbladder contraction and secretion of cholecystokinin and pancreatic polypeptide in man.
    Hopman WP, de Jong AJ, Rosenbusch G, Jansen JB, Lamers CB.
    Dig Dis Sci; 1987 Jan 18; 32(1):45-9. PubMed ID: 3539560
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. In vitro effects of pancreatic polypeptide and motilin on contractility of human gallbladder.
    Pomeranz IS, Davison JS, Shaffer EA.
    Dig Dis Sci; 1983 Jun 18; 28(6):539-44. PubMed ID: 6861584
    [Abstract] [Full Text] [Related]

  • 56. Role of cholecystokinin in mediating GRP-stimulated gastric, biliary and pancreatic functions in man.
    Hildebrand P, Drewe J, Luo H, Ketterer S, Gyr K, Beglinger C.
    Regul Pept; 1992 Sep 22; 41(2):119-29. PubMed ID: 1438984
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW.
    J Physiol Pharmacol; 1994 Dec 22; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.